$47.46
$62.17
Poviztra 0.25 mg is a pharmaceutical product for patients suffering from type 2 diabetes and weight loss. It is produced by Novo Nordisk India Pvt. Ltd. The drug is administered via a user-friendly FlexTouch pre-filled pen for a subcutaneous injection once a week. Poviztra 0.25 mg Product Information What is Poviztra 0.25 mg, a Diabetes and Weight Management Medication? Poviztra is a drug that consists of semaglutide, an agonist of glucagon-like peptide-1 (GLP-1) receptors that emulates the natural GLP-1 hormone released post-meal. Semaglutide promotes the secretion of insulin and cuts down the secretion of glucagon depending on the level of glucose in the blood, thereby controlling blood sugar more effectively. Besides, the drug hastens the emptying of the stomach and lessens the desire to eat, thus facilitating weight control. What are the Medical Uses of Poviztra Semaglutide? Poviztra semaglutide is primarily indicated for: Management of Type 2 Diabetes: Serving as an adjunct to diet and exercise to bring about glycemic control in adults with type 2 diabetes mellitus. Reduction of Cardiovascular Risk: Heart attack, stroke, or death among adults with type 2 diabetes who also have heart disease. Protection Against Chronic Kidney Disease: Kidney failure, and cardiovascular death in patients with type 2 diabetes and chronic kidney disease. Weight Management: For long-term weight management of adults suffering from obesity. How Does Semaglutide 0.25 mg Work in the Body? Semaglutide encourages the pancreatic beta-cells to release insulin when the blood glucose levels are high, and on the contrary, the alpha-cells reduce glucagon production. Besides, semaglutide also affects gastric emptying, which leads to longer satiety, and it also interacts with the brain centers that control appetite and, thus, leads to less hunger, which is a great help in weight loss. To understand how this medication supports fat loss and appetite control, read our detailed guide on semaglutide for weight loss and how it works for long-term obesity management. What are the Dosage and Administration Guidelines for Poviztra? Semaglutide dosing should always be determined by a qualified healthcare professional considering: Treatment objectives (either diabetes control or weight loss) Patient’s general health status Patient’s heart and kidney health Patient’s ability to tolerate the medication during dose increase Any other medical conditions the patient has Take 0.25 mg subcutaneously once a week for the first 4 weeks. Inject it under the skin of the abdomen, thigh, or upper arm at the same day each week, any time, with or without meals. After Week 5, the healthcare provider will raise the dosage to 0.5 mg once a week. Change the injection site weekly. Do not share pre-filled syringes with anyone. What Are the Pricing and Packaging Options Available? Note: Each pen includes 4 disposable needles Patients looking to reduce treatment costs can also explore available discounts through our Semaglutide coupon offers, which may help make long-term therapy more affordable. What are the Side Effects of Semaglutide 0.25 mg? Common Side Effects: Nausea (most frequent, generally subsides with time) Vomiting Diarrhea Stomach upset or pain in the abdomen Constipation Feeling tired or drained Dizziness or feeling faint Pain in the head Lessened desire to eat Gas and bloating Serious Side Effects (Rare): Severe inflammation of the pancreas Tumors of the thyroid C-cells including medullary thyroid carcinoma Reactions (anaphylaxis, angioedema, rash, hives) Prompt kidney failure or kidney function deterioration Eye disease complications due to diabetes Disease of the gallbladder (gallstones, inflammation of the gallbladder) Reduced blood sugar level (when taken with insulin or sulfonylureas) Severe loss of fluids due to constant vomiting or diarrhea If any serious side effect occurs, call for an immediate discontinuation of the drug and medical consultation. Some patients also worry about sexual health effects. You can learn more in our medically reviewed article on does semaglutide cause erectile dysfunction. Who Should Avoid Semaglutide Treatment? Absolute Contraindications: Personal or Family History of MTC: Not to be given to patients having personal or family history of medullary thyroid carcinoma or MEN 2. Known Hypersensitivity: Very rarely, severe allergic reactions or even anaphylaxis can happen with semaglutide or any of its components. Pregnancy Planning: While using semaglutide and for 2 months after the last dose, becoming pregnant should be avoided as it might have an adverse effect on the fetus. Medical Conditions Requiring Caution: History of Pancreatitis: Pancreatitis history has not been studied in patients; consider other medication. Diabetic Retinopathy: Monitor very closely because complications may develop. Kidney Disease: In patients with renal impairment, caution is advised; adjustment of the dosage might become necessary. Gastrointestinal Disease: Patients with gastroparesis or inflammatory bowel disease may worsen their condition. Elderly Patients: Elderly patients are usually more sensitive to the effects of the medication than younger adults. Planned Surgery: Patients undergoing surgery have an increased risk of aspiration during anesthesia; the drug should be stopped before elective procedures. Drugs that Interact with Semaglutide: Insulin and Insulin Secretagogues: The risk of hypoglycemia is increased; thus, a reduction in the dosage may be necessary. Oral Medications: The delayed gastric emptying can lead to poor absorption of the oral drugs. Other GLP-1 Agonists: Patients should not take any other product containing semaglutide or similar medications (exenatide, dulaglutide) at the same time. Warfarin: More frequent INR monitoring is required when starting or changing the dose of semaglutide. How Should Semaglutide Pens Be Stored? Before first use: Refrigerate between 36°F to 46°F (2°C to 8°C) until the expiration date After first use: The storage can be at room temperature 59°F to 86°F (15°C to 30°C) or in the refrigerator, not exceeding 56 days Always keep the pen capped when not in use to prevent light from affecting it Freezing is not allowed; if frozen, the pen should be discarded Pens should be disposed of 56 days after the first use or when the dose counter shows less than 0.25 mg Keep out of reach of children and pets Refrigerate but do not store near the cooling element Avoid exposure to heat and direct sunlight Store with needle removed What Safety Precautions Must Be Followed? Inject once weekly on the same day each week Rotate injection sites to prevent lipodystrophy Check liquid before use; should be clear and colorless. Do not use if cloudy, discolored, or has particles Never share pens even if needle is changed Use new needle for each injection Dispose of needles in puncture-proof sharps container Monitor blood glucose regularly if diabetic Report persistent abdominal pain immediately Stay hydrated, especially if experiencing nausea or vomiting Carefully follow meal plan and exercise program recommended by your doctor Inform all healthcare providers about semaglutide use Do not mix with insulin in same syringe If you are experiencing ongoing sexual health concerns, visit our erectile dysfunction treatment section for medically approved solutions and expert guidance. Frequently Asked Questions 1. Is 0.25 mg a therapeutic dose? No, the 0.25 mg dose is a non-therapeutic starting dose for the first 4 weeks to help your body adjust. Your doctor will increase to 0.5 mg at week 5, which is the first therapeutic maintenance dose. 2. How long do I stay on 0.25 mg? Take 0.25 mg once weekly for 4 weeks, then your healthcare professional will increase the dose. This gradual escalation minimizes gastrointestinal side effects like nausea. 3. Can I take semaglutide with food? Yes, semaglutide can be taken at any time of day, with or without meals. The day of weekly administration can be changed if needed as long as at least 48 hours pass between doses. 4. What if I miss a dose? If missed, administer as soon as possible within 5 days. If more than 5 days have passed, skip the missed dose and resume regular weekly schedule. 5. Will I lose weight on 0.25 mg? Clinical trials showed sustained weight loss with semaglutide 2.4 mg maintenance dose, with 86% achieving at least 5% weight loss. However, 0.25 mg is only a starter dose, not intended for weight loss results. Disclaimer: This product information is for educational purposes only and should not replace professional medical advice. Always consult qualified healthcare providers before starting semaglutide treatment. Follow your doctor’s prescription instructions carefully. Semaglutide requires proper dose escalation under medical supervision.
Diabetes
